Item 1
1(a) Name of Issuer: Intra-Cellular Therapies, Inc.
1(b) Address of Issuers Principal Executive Offices:
430 East 29th Street, Suite 900, New York, NY 10016
Item 2
2(a) Name of Person
Filing: BB Biotech AG (BB Biotech) on behalf of its wholly-owned subsidiary, Biotech Target N.V. (Biotech Target).
2(b) Address of Principal Business Office or, if none, Residence:
BB Biotech AG: Schwertstrasse 6, CH-8200 Schaffhausen, Switzerland
Biotech Target N.V.: Ara Hill Top Building, Unit A-5, Pletterijweg Oost 1, Curaçao
2(c) Citizenship: BB Biotech AG: Switzerland
Biotech Target N.V.: Curacao
2(d) Title of Class of Securities Common Stock, $0.0001 par value
2(e) CUSIP Number 46116X101
Item 4. Ownership
Provide the
following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned: 3,538,419
(b) Percent of class: 4.4%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote 0
(ii) Shared power to vote or to direct the vote 3,538,419
(iii) Sole power to dispose or to direct the disposition of 0
(iv) Shared power to dispose or to direct the disposition of 3,538,419
ITEM 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of
more than five percent of the class of securities, check the following ☒.
4 of 7